A rare chance to build wealth after the stock market correction!

Dr James Fox details his strategy to build wealth by investing in undervalued parts of the stock market after the correction.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Young Asian woman holding a cup of takeaway coffee and folders containing paperwork, on her way into the office

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Stock market volatility has returned over the past week. But over the long run, several sectors in the UK have suffered. In fact, over three years, the FTSE 350 is only up around 2% (up 1% over one year) — clearly that’s not great. Broadly speaking, resource stocks have surged while sectors like banking, retail, travel and housebuilding have suffered.

While this market hasn’t been kind to investors, it does create opportunities to buy top-quality stocks at discounted prices. And, specifically, I’m looking for opportunities in areas of the market that have underperformed.

Here’s what I’m hunting for.

Should you invest £1,000 in Novacyt S.a. right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Novacyt S.a. made the list?

See the 6 stocks

Discounted stocks

Stocks may appear cheap if they’re trading for less than they did a year ago. But I want shares that are actually undervalued. Having said this, I contend that I stand a better chance of finding undervalued shares within bear markets.

But this is where I need to do my research. There’s no best way to value stocks, but I can use both near-term and long-term valuations to generate a good understanding. Near-term valuations include the EV-to-EBITDA ratio or the price-to-earnings metric. And I need to compare these among peers within a sector.

Many websites, including the Hargreaves Lansdown platform, will provide me with this data, so all I have to do is compare stocks in similar sectors. 

The discounted cash flow model is an example of a long-term valuation model. If done correctly, I can build a better idea of the value of my investment over a period of time. However, it does require me to make estimations regarding future cash flow, and this can be challenging.

My value picks

Buying undervalued shares and holding them for the long run is generally referred to as value investing. Value investing strategies, such as that of billionaire super-investor Warren Buffett, have constantly outperformed major indices over the past century.

So I’m looking at stocks with near-term valuations below their peers and discounted cash flow calculations that suggest the stock is undervalued.

For example, GSK trades with a P/E ratio of 13, versus a sector average of around 25. However, it’s worth noting that GSK, like many other pharma’s and biotechs, has a substantial amount of debt. So I need to look at the EV-to-EBITDA ratio, which is 6.8 versus a sector average of 15.8.

It’s clear therefore that GSK is undervalued versus its peers. But this could also reflect the risk associated with further Zantac lawsuits, despite a court dismissing cases towards the end of last year.

Meanwhile, a discounted cash flow calculation suggests the stock is undervalued by around 20%. This is clearly positive. But it’s worth highlighting the challenges forecasting cash flow in this sector as future performance is largely dependent on the success of drug and treatment trials.

I recently bought GSK shares, but there are more attractive value picks out there. Lloyds and Barclays are undervalued by 60% and 70% respectively, according to discounted cash flow models. That’s why I’m buying more.

Like buying £1 for 31p

This seems ridiculous, but we almost never see shares looking this cheap. Yet this Share Advisor pick has a price/book ratio of 0.31. In plain English, this means that investors effectively get in on a business that holds £1 of assets for every 31p they invest!

Of course, this is the stock market where money is always at risk — these valuations can change and there are no guarantees. But some risks are a LOT more interesting than others, and at The Motley Fool we believe this company is amongst them.

What’s more, it currently boasts a stellar dividend yield of around 10%, and right now it’s possible for investors to jump aboard at near-historic lows. Want to get the name for yourself?

See the full investment case

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

James Fox has positions in Barclays Plc, GSK, Hargreaves Lansdown Plc, and Lloyds Banking Group Plc. The Motley Fool UK has recommended Barclays Plc, GSK, Hargreaves Lansdown Plc, and Lloyds Banking Group Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Just released: our 3 top small-cap stocks to consider buying in April [PREMIUM PICKS]

Small-cap shares tend to be more volatile than larger companies, so we suggest investors should look to build up a…

Read more »

Investing Articles

Here’s why Tesla stock just rocketed 22.7%! Is it time to buy?

This writer wonders whether the news that sent Tesla stock soaring yesterday is a true gamechanger for the electric vehicle…

Read more »

Investing Articles

2 quality UK stocks to consider buying as share prices rally

With UK stocks moving higher, it might look as though investors with cash on hand have missed their chance. But…

Read more »

Investing Articles

How much £10,000 invested in Lloyds shares is forecast to be worth in 12 months

Harvey Jones is looking past today's stock market volatility to see where Lloyds shares may stand in a year's time.…

Read more »

Investing Articles

How Warren Buffett stays ahead of the stock market

When share prices fall, everyone suddenly wants to be like Warren Buffett. But what’s the secret to the Berkshire Hathaway…

Read more »

Investing Articles

Cheap UK dividend shares to consider buying right now

We're only just past the first quarter of 2025, but it already looks like the year could be another good…

Read more »

Young Asian woman with head in hands at her desk
Investing Articles

What the heck is going on with the Barclays share price now?

The Barclays share price surged 25% as the market open on 10 April. Once again, the volatility’s been driven by…

Read more »

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

What the devil’s going on with the HSBC share price?

The HSBC share price has actually been less volatile than some of its peers, despite its Chinese operations suggesting it’s…

Read more »